哈药股份2025年一季度营收微增，净利润显著提升但需关注现金流与应收账款

证券之星2025-04-27

近期哈药股份(600664)发布2025年一季报，证券之星财报模型分析如下：财务概况近期哈药股份(600664)发布了2025年一季报。报告显示，哈药股份在该季度实现营业总收入41.74亿元，同比上升0.78%；归母净利润2.13亿元，同比上升20.48%；扣非净利润2.04亿元，同比上升28.06%。主要财务指标毛利率：26.66%，同比下降6.15%。净利率：5.24%，同比增加14.05%。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530117731?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-27 06:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2530117731","market":"sh","top_or_hot":-1,"title":"哈药股份2025年一季度营收微增，净利润显著提升但需关注现金流与应收账款","media":"证券之星","content":"<div>\n<p>近期哈药股份(600664)发布2025年一季报，证券之星财报模型分析如下：财务概况近期哈药股份(600664)发布了2025年一季报。报告显示，哈药股份在该季度实现营业总收入41.74亿元，同比上升0.78%；归母净利润2.13亿元，同比上升20.48%；扣非净利润2.04亿元，同比上升28.06%。主要财务指标毛利率：26.66%，同比下降6.15%。净利率：5.24%，同比增加14.05%。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427063637a6c9b81d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>哈药股份2025年一季度营收微增，净利润显著提升但需关注现金流与应收账款</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n哈药股份2025年一季度营收微增，净利润显著提升但需关注现金流与应收账款\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-27 06:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427063637a6c9b81d&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近期哈药股份(600664)发布2025年一季报，证券之星财报模型分析如下：财务概况近期哈药股份(600664)发布了2025年一季报。报告显示，哈药股份在该季度实现营业总收入41.74亿元，同比上升0.78%；归母净利润2.13亿元，同比上升20.48%；扣非净利润2.04亿元，同比上升28.06%。主要财务指标毛利率：26.66%，同比下降6.15%。净利率：5.24%，同比增加14.05%。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427063637a6c9b81d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159399","symbol_name":"现金流","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427063637a6c9b81d&s=b","article_id":"2530117731","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427063637a6c9b81d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2530117731","pubTimestamp":1745706645,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近期哈药股份发布2025年一季报，证券之星财报模型分析如下：财务概况近期哈药股份发布了2025年一季报。报告显示，哈药股份在该季度实现营业总收入41.74亿元，同比上升0.78%；归母净利润2.13亿元，同比上升20.48%；扣非净利润2.04亿元，同比上升28.06%。综上所述，哈药股份在2025年一季度实现了营收和净利润的增长，但毛利率有所下降，且现金流和应收账款方面存在潜在风险，需持续关注。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"159399":"现金流","600664":"哈药股份"},"translate_title":"Harbin Pharmaceutical Co., Ltd. 's revenue increased slightly in the first quarter of 2025, and its net profit increased significantly, but it is necessary to pay attention to cash flow and accounts receivable","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159399":1,"600664":1},"content_text":"近期哈药股份(600664)发布2025年一季报，证券之星财报模型分析如下：财务概况近期哈药股份(600664)发布了2025年一季报。报告显示，哈药股份在该季度实现营业总收入41.74亿元，同比上升0.78%；归母净利润2.13亿元，同比上升20.48%；扣非净利润2.04亿元，同比上升28.06%。主要财务指标毛利率：26.66%，同比下降6.15%。净利率：5.24%，同比增加14.05%。三费占营收比：18.75%，同比下降13.07%。每股净资产：2.21元，同比增加13.63%。每股经营性现金流：-0.18元，同比下降71.75%。每股收益：0.08元，同比增加14.29%。资产负债情况货币资金：28.02亿元，同比下降1.58%。应收账款：48.88亿元，同比增加3.63%。有息负债：13.21亿元，同比下降33.29%。经营业绩与商业模式根据证券之星价投圈财报分析工具显示，哈药股份去年的ROIC为9.42%，资本回报率一般；净利率为4.27%，表明公司产品或服务的附加值不高。公司业绩主要依靠营销驱动，需要进一步研究这种驱动力的实际效果。风险提示财报体检工具建议关注以下方面：现金流状况：货币资金与流动负债的比例仅为54.05%，近3年经营性现金流均值与流动负债的比例仅为15.2%，显示出一定的现金流压力。应收账款状况：应收账款与利润的比例高达777.37%，应收账款回收风险值得关注。综上所述，哈药股份在2025年一季度实现了营收和净利润的增长，但毛利率有所下降，且现金流和应收账款方面存在潜在风险，需持续关注。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530117731","isCrawlerRequest":true}